-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
6667px;white-space:normal;'> 6667px;">
6667px;">6667px;white-space:normal;'> 6667px;">The National Two Sessions in 2021 are being held in full swing.
As the pillar industry of people’s livelihood and health, the pharmaceutical industry has always been the focus of the people’s attention.
This year, how do pharmaceutical professionals practice the mission of a healthy China and which medical hot words have received the most attention and heated discussions.
? What kind of development trend does it reveal? Let's take a look.
Pharmaceutical innovation.
6667px;">The National Two Sessions in 2021 are being held in full swing.
biomedicine
6667px;white-space:normal;caret-color:#333333;'>
Since Henlius's rituximab was approved for marketing in 2019, domestic biosimilars (the first biosimilar in China) have developed rapidly.
At the same time, China's biopharmaceutical industry has also entered a period of rapid development.
According to data from Yaozhi, in 2020, CDE biological products have received 404 new drug acceptance numbers, of which 59 are new drug acceptance numbers reported for production; 51 biological products have been approved for production or import in 2020, an increase of 54.
54% year-on-year, domestic innovation Biological products are speeding up on the market and are gradually moving towards the harvest period.
New crown vaccine
6667px;white-space:normal;caret-color:#333333;'> At present, many countries around the world are working hard to research and increase the production of new crown vaccines.
At the press conference of the Fourth Session of the 13th National Committee of the Chinese People’s Political Consultative Conference, the spokesperson of the Congress Guo Weimin said that as of the end of February, my country had received more than 52 million doses of COVID-19 vaccine, and China provided vaccine assistance to 69 countries and two international organizations.
, And export vaccines to 28 countries.
In the future, about 100 countries will use the new crown vaccine produced in China.
Development of Traditional Chinese Medicine
Chinese Medicine Development Internet + Chinese Medicine